The movement toward decentralized, virtual clinical trials requires many different digital devices, from smart phones and tablets and various apps to specialized wearables powered by specialized sensor technology. TrialSite wanted to learn more about wireless sensors via an interview with Shimmer. Headquartered in Dublin, with offices in Boston, Shimmer provides wearable sensor technology, including its wireless sensing platform for clinical trials called Verisense. As the move to remote research can at times necessitate the use of wireless-based sensor technology, TrialSite’s Daniel O’Connor recently spoke with Geoffrey Gill, President of Shimmer Americas, to learn more about this important suite of technologies. What follows is that interview.
Can you share with us company background, history, how it got started, funded and what has propelled it to this level?
>> Shimmer’s origins go back to the early 2000s when Intel was funding research into wearable sensor applications. Intel realized that researchers were spending most of their Intel grants on reinventing the wheel – designing electronics with a sensor, microprocessor, memory, communications, etc. ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).